Physician profile
Jason Cundiff
NPI 1497926323
$234,503.13
in general payments reported to CMS, 2019-2025
11 companies · $500 in 2025
The $500 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $4,315 · 2021: $30K · 2022: $128K · 2023: $43K · 2024: $13K · 2025: $500.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Education: $12K · Travel and Lodging: $11K · Food and Beverage: $2,841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,000.00 |
| Education | $12,000.00 |
| Travel and Lodging | $11,445.13 |
| Food and Beverage | $2,841.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $233,579.12 | 2019-2025 | Da Vinci Sp, Da Vinci Surgical System |
| Conmed Corporation | $352.75 | 2021-2024 | Airseal, Conmed Pads and Pencils, Conmed Specimen Retrieval |
| Inspire Medical Systems, INC. | $246.62 | 2023-2024 | Inspire |
| Davol INC. | $133.85 | 2023-2024 | Channel Drain, Phasix Mesh |
| Becton, Dickinson and Company | $65.60 | 2023 | Phasix Mesh |
| Innovation Technologies INC | $41.91 | 2021-2023 | Irrisept |
| Merck Sharp & Dohme LLC | $28.24 | 2023 | Keytruda, Lynparza |
| Boston Scientific Corporation | $15.19 | 2019 | |
| Smith+Nephew, INC. | $14.39 | 2023 | Stravix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.30 | 2019 | |
| Novo Nordisk INC | $12.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Cundiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.